Medi-Tate
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Trojan Business Park Cobbold Rd, Londo...Phone Number
+86 1089478257Website
www.medi-tate.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Medi-Tate
Medi-Tate is an Israeli medical device company dedicated to improving men’s healthcare and quality of life via effective, non-surgical solutions for Benign Prostatic Hyperplasia (BPH). The flagship iTind treatment for BPH currently has the EU CE Mark and is approved for sale in the European Union, UK, Israel, Australia, and Brazil, and the FDA cleared for use in the United States.Explore more
Medi-Tate Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medi-Tate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Medi-Tate had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Medi-Tate
Check if Medi-Tate has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Medi-Tate recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Medi-Tate is spiking on competitors!
Product Launch: Get notified when Medi-Tate launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Medi-Tate has new funding data
Medi-Tate, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Medi-Tate as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Medi-Tate is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medi-Tate is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medi-Tate.
Medi-Tate financials insights
Gather financial insights about Medi-Tate, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$2M
Medi-Tate Tech Stack
A closer look at the technologies used by Medi-Tate
See more technologies
Medi-Tate News & Media
Olympus acquires Israel-based Medi-Tate
Olympus announced that it finalized the acquisition of benign prostatic hyperplasia treatment developer Medi-Tate.Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
TOKYO & HAMBURG, Germany & CENTER VALLEY, Pa.--(BUSINESS WIRE)--Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd. (“Medi-Tate” – CEO: Ido Kilemnik) following the announcement of its decision to exercise the call option in February, 2021. Through this acquisition, Olympus expands its business line in offering in-office treatment forOlympus übt Option auf Kauf des israelischen Medizinproduktherstellers Medi-Tate aus, um den Geschäftsbereich Urologie global zu stärken
HAMBURG & TOKIO--(BUSINESS WIRE)--Die Olympus Corporation („Olympus“ – Director, Representative Executive Officer, President und CEO: Yasuo Takeuchi) hat heute bekannt gegeben, dass sie ihre Kaufoption auf die übrigen Anteile an der Medi-Tate Ltd. („Medi-Tate“, einem israelischen Medizinprodukthersteller, CEO: Ido Kilemnik) ausübt. Die mögliche Akquisition würde Olympus‘ Therapeutic Solutions Division, eine wichtige Säule der Wachstumsstrategie des Unternehmens, weiter stärken, und die PositionOlympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
TOKYO & HAMBURG, Germany--(BUSINESS WIRE)--Olympus Corporation announced that it has exercised its call option in respect of the remainder of the shares in Medi-Tate Ltd.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medi-Tate
Sign Up For FreeTo access detailed company insights
Medi-Tate is an Israeli medical device company dedicated to improving men’s healthcare and quality of life via effective, non-surgical solutions for Benign Prostatic Hyperplasia (BPH). The flagship iTind treatment for BPH currently has the EU CE Mark and is approved for sale in the European Union, UK, Israel, Australia, and Brazil, and the FDA clea... Read More
